Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
25.60
-0.41 (-1.58%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.26 billion as of August 28, 2026. Its market cap has increased by 124.45% in one year.
Market Cap
2.26B
Enterprise Value
1.70B
1-Year Change
124.45%
Ranking
Category
Stock Price
$25.60
ChartMarket Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.26B, an increase of 262.17%. That is a compound annual growth rate of 43.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.26B | -21.20% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 2.43B |
| Kailera Therapeutics | 2.40B |
| Ocular Therapeutix | 2.38B |
| Harmony Biosciences Holdings | 2.32B |
| Hemab Therapeutics Holdings | 2.31B |
| Sarepta Therapeutics | 2.28B |
| Nanobiotix | 2.28B |
| Mesoblast | 2.25B |